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ABSTRACT 29 
 We determined how the extra- and intra-cranial circulations respond to 30 
generalized sympathetic activation evoked by a cold pressor test (CPT) and whether 31 
this was affected by healthy aging. Ten young (23±2 yr; mean±SD) and nine older 32 
(66±3 yr) individuals performed a 3-min CPT by immersing the left foot into 33 
0.8±0.3°C water. Common carotid artery (CCA) and internal carotid artery (ICA) 34 
diameter, velocity and flow were simultaneously measured (duplex ultrasound), along 35 
with middle cerebral artery and posterior cerebral artery mean blood velocity 36 
(MCAvmean and PCAvmean), and cardiorespiratory variables. The increases in heart rate 37 
(~6 bpm) and mean arterial blood pressure (~14 mmHg) were similar in young and 38 
older groups during the CPT (P<0.01 vs. baseline). In the young group, the CPT 39 
elicited a ~5% increase in CCA diameter (P<0.01 vs. baseline) and tendency for an 40 
increase in CCA flow (~12%; P=0.08); in contrast, both diameter and flow remained 41 
unchanged in the older group. Although ICA diameter was not changed during the 42 
CPT in either group, ICA flow increased (~8%; P=0.02) during the first minute of the 43 
CPT in both groups. While the CPT elicited an increase in MCAvmean and PCAvmean in 44 
the young group (by ~20% and ~10%, respectively; P<0.01 vs. baseline), these intra-45 
cranial velocities were unchanged in the older group. Collectively, during the CPT, 46 
these findings suggest a differential mechanism(s) of regulation between the ICA 47 
compared to the CCA in young individuals, and a blunting of the CCA and intra-48 
cranial responses in older individuals.  49 
 3 
New & Noteworthy 50 
Sympathetic activation evoked by a cold pressor test elicits heterogeneous extra- and 51 
intra-cranial blood vessel responses in young individuals that may serve an important 52 
protective role. The extra- and intra-cranial responses to the cold pressor test are 53 
blunted in older individuals. 54 
 55 
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 57 
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INTRODUCTION 60 
The cold pressor test (CPT) has been widely employed for the assessment of 61 
human autonomic function (13, 17), peripheral vascular reactivity (7, 45, 53, 72) and 62 
cardiovascular risk stratification (6, 38, 61). However, the cerebrovascular responses 63 
to the CPT remain poorly understood, particularly in healthy aging and chronic 64 
disease. This issue is compounded by the controversy surrounding the sympathetic 65 
regulation of the extra- and intra-cranial blood vessels (1, 58). During the CPT, 66 
signals from activated cutaneous thermoreceptor and nociceptor afferents are rapidly 67 
integrated within the central nervous system (principally the hypothalamic and 68 
medullary regions) and lead to the activation of cortical sites (10). This activation 69 
elevates peripheral vascular resistance, HR and blood pressure (23) on account of the 70 
characteristic autonomic efferent response, consisting of a robust increase in 71 
sympathetic nerve activity (SNA) [e.g., increased plasma noradrenaline (19) and 72 
muscle sympathetic nerve activity (65)], and potentially a decrease in cardiac 73 
parasympathetic nerve activity [e.g., decreased HR variability (16)]. Cerebral blood 74 
flow may be affected by several mechanisms during the CPT, including neurovascular 75 
coupling, a hydraulic pressure effect even in the absence of a change in vascular 76 
resistance, local autoregulatory mechanisms, and by the sympathetic modulation of 77 
extra- and intra-cranial blood vessels. 78 
In animal studies, innervation of the CCA, ICA and intra-cranial vasculature 79 
by postganglionic sympathetic nerve fibers has been identified (12, 37, 42); electrical 80 
stimulation of sympathetic nerves can evoke cerebral vasoconstriction (2, 66); and 81 
norepinephrine causes vasoconstriction in cerebral microvessels (36, 59). In humans, 82 
the spillover of noradrenaline from the brain into the internal jugular vein has been 83 
reported (43); clinically indicated upper thoracic sympathectomy increases ICA 84 
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diameter and flow (26); and stellate ganglion blockade reportedly increases cerebral 85 
perfusion (62), although this is not been a universal finding (27). The effect of CPT-86 
evoked sympathoexcitation on cerebral perfusion has principally been evaluated in 87 
terms of intra-cranial artery mean blood flow velocity and usually within the middle 88 
cerebral artery (MCAvmean). Intriguingly, both reductions (3, 41) and elevations (46, 89 
47, 56, 73) in cerebral perfusion have been reported during the CPT, possibly due to 90 
differences in the partial pressure of arterial carbon dioxide (PaCO2). With respects to 91 
the regulation of extra-cranial blood flow during the CPT, an increase in common 92 
carotid artery (CCA) diameter by ~8% is reported in young healthy individuals (28, 93 
34, 53). In contrast, CCA diameter is reduced during the CPT in patients with 94 
coronary artery disease, possibly due to the greater sensitivity of the a-adrenergic 95 
receptors (53). Unfortunately, to date no assessment has been made of internal carotid 96 
artery (ICA) diameter or volumetric flow during the CPT, but these are essential in 97 
order to understand the implications for cerebral blood flow (as opposed to blood flow 98 
to the head and scalp via the external carotid artery). It would seem unlikely that the 99 
same responses were observed in the CCA and ICA during the CPT. In accordance 100 
with Poiseuille’s Law, small changes in diameter have a major effect on flow (e.g., 101 
flow a (diameter/2)4). Accordingly, if the ICA were to dilate to a similar degree as the 102 
CCA (e.g., ~8%) brain blood flow would increase markedly. Given that the brain 103 
seems to be particularly effective at protecting itself from over-perfusion (68) and that 104 
the ICA (and vertebral arteries) are known to be integral to the regulation of cerebral 105 
blood flow through modifying vascular resistance (14, 22, 29, 39, 40), it seems 106 
reasonable to expect that different responses occur in the CCA and ICA during the 107 
CPT. 108 
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Increased age is associated with a multitude of structural, functional and 109 
regulatory alterations throughout the cardiovascular system (30, 31), including the 110 
brain (5, 54). Age-related increases in arterial stiffness (28, 33), impairments in 111 
endothelial vasodilator function and altered a- and b-adrenergic receptors signaling 112 
within the peripheral vasculature have been identified in humans (4, 11). However, 113 
the extent to which age modifies the cerebral blood flow responses to sympathetic 114 
stimulation remains unclear. 115 
The purpose of this study was two-fold. First, to comprehensively describe the 116 
extra- (CCA, ICA) and intra-cranial (MCA) blood flow responses to the CPT. Second, 117 
to ascertain the influence of age on these cerebrovascular responses to the CPT. To 118 
achieve these goals, in both younger and older subjects, simultaneous measurements 119 
of CCA and ICA diameter, velocity and flow were made along with MCAvmean and 120 
posterior cerebral artery mean blood flow velocity (PCAvmean) during the CPT under 121 
conditions of controlled isocapnia. We hypothesized that there would be less of an 122 
increase in ICA diameter compared to the CCA during the CPT in young individuals. 123 
In addition, we anticipated that the extra- and intra-cranial responses to the CPT 124 
would be blunted in older individuals.  125 
 126 
MATERIALS AND METHODS 127 
Ethical Approval 128 
All experimental protocols and procedures were approved by the University of 129 
British Columbia Research Ethics Board (H15-01951) and conformed to the 130 
Declaration of Helsinki. Prior to participation a detailed verbal and written 131 
explanation of the study was provided and each participant completed written 132 




Nineteen study participants, ten young (2 women, 23±2 years, 176±7 cm, 136 
73±9 kg, mean±SD) and nine older (2 women, 66±3 years, 176±8 cm, 78±13 kg) took 137 
part in the study. As determined by a written screening questionnaire and oral 138 
confirmation, no study participants had a history of cardiovascular, cerebrovascular or 139 
respiratory disease. None of our participants were active smokers, except one of the 140 
older participants had a history of smoking. Participants were not taking prescription 141 
or over-the-counter medications, except for two of the older male study participants 142 
who were using either Tamsulosin (0.4mg/day) due to enlarged prostate or 143 
Ciclesonide (400µg/day) due to mild asthma, and the two young women who were 144 
taking oral contraceptives and were tested on day 1 and 2 of their self-reported 145 
menstrual cycle. The two older women were both postmenopausal and not taking 146 
hormone replacements. Participants abstained from alcohol, caffeine and exercise for 147 
at least 12 hr prior to the experimental session. 148 
 149 
Experimental measures 150 
Cardiorespiratory measures 151 
Heart rate (HR) was assessed using a 3-lead electrocardiogram (ECG; ADI 152 
BioAmp ML132), and beat-to-beat blood pressure using a finger 153 
photoplethysmography (Finometer PRO, Finapres Medical Systems, Amsterdam, 154 
Netherlands). Mean arterial pressure (MAP) was calculated from the Finometer 155 
reconstructed brachial waveform after values were back calibrated to the average of 156 
three automated brachial blood pressure measurements made over 3-min (Tango+; 157 
SunTech, Morrisville, NC). Stroke volume (SV) was estimated using the Modelflow 158 
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method (FMS, Amsterdam, The Netherlands), which simulates aortic flow waveforms 159 
from an arterial pressure signal using a non-linear three-element model of the aortic 160 
input impedance. Cardiac output (CO) was calculated as SV x HR, and total 161 
peripheral resistance (TPR) as MAP / CO. Both the partial pressure of end-tidal CO2 162 
(PetCO2) and O2 (PetO2) were sampled at the mouth and recorded by a calibrated gas 163 
analyzer (model ML206, ADInstruments). A pneumotachograph (model HR 800L, 164 
Hans Rudolph, Shawnee, KS) connected to a bacterial filter was used to assess minute 165 
ventilation (VE). All cardiorespiratory variables were sampled continuously at 1000 166 
Hz using an analogue-to-digital converter (Powerlab, 16/30; ADInstruments, 167 
Colorado Springs, CO, USA) and data were interfaced with LabChart (Version 7), and 168 
analyzed offline. 169 
 170 
Cerebrovascular measures 171 
Transcranial Doppler Ultrasound (2MHz, TCD, Spencer Technologies, 172 
Seattle, WA) was used to simultaneously assess the right MCAvmean and left 173 
PCAvmean, in accordance with standard guidelines (67). A 2 MHz wavelength 174 
provides the optimal resolution-to-penetration depth ratio for imaging the deep 175 
cerebral vessels. The transmitted ultrasound beam contacts the red blood cells within 176 
the target vessel and a portion of the signal is reflected back to the transducer. 177 
The difference between the emitted and received frequency signals (i.e., Doppler 178 
shift) is processed through a fast Fourier transformation to produce a velocity trace 179 
and an envelope surrounding this is then exported in real time into LabChart (Version 180 
7) for offline analyses. For anatomical reasons, in two older individuals the 181 
orientation was switched such that the left MCAvmean and right PCAvmean were 182 
insonated. Despite switching side in one individuals a clear image was impossible, 183 
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therefore PCAvmean is based on n = 8. The bilaterally placed probes were secured in 184 
place by being attached to a headpiece (model M600 bilateral head frame, Spencer 185 
Technologies).  The MCA and PCA were insonated through the middle trans-186 
temporal window, using previously described locations and standardization 187 
techniques (67). Blood velocity and vessel diameter of the left common carotid artery 188 
(CCA, right CCA n=3) and right internal carotid artery (ICA, left ICA n=3) were 189 
measured using a 10 MHz multi-frequency linear array vascular ultrasound (Terason 190 
T3200, Teratech, Burlington, MA). Due to anatomical reasons a clear image of the 191 
target artery was not possible in three study participants and therefore the side of 192 
insonation was switched. Only in two study participants were the ICA and MCA 193 
insonated contralaterally. B-mode imaging was used to measure arterial diameter, 194 
while pulse-wave mode was used to simultaneously measure peak blood velocity. 195 
Extracranial blood flow measurements were made in accordance with recent technical 196 
recommendations (60). All CCA and ICA recordings were screen captured and stored 197 
as video files for offline analysis (70). A minimum of 10 consecutive cardiac cycles 198 
were used to determine extracranial blood flow measurements. In 2 older study 199 
participants ICA images were on insufficient quality, thus ICA analysis in this cohort 200 
is based on n=7. Volumetric blood flow was calculated using the following formula:  201 
 202 
CCA	or	ICA	flow = CCA	or	ICA	Peak	Envelope	Velocity	2 ∙ [𝜋	(0.5	 ∙ Diameter)C] 203 
 204 
Cerebrovascular conductance (CVC) was calculated for intracranial arteries and 205 
extracranial arteries using the following formula: 206 
 207 
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MCA, PCA, CCA	or	ICA	CVC	 = MCA𝑣HIJK, PCA𝑣HIJK, CCA	flow	or	ICA	flowMAP  208 
 209 
Several indices of CCA and ICA stiffness were calculated in accordance with recently 210 
published methods (33, 34). β-stiffness index = ln(SBP-DBP)/[(DIAsys-211 
DIAdia)/DIAdia], Elastic modulus = [(SBP-DBP)·DIAdia]/(DIAsys-DIAdia), arterial 212 
compliance = (DIAsys-DIAdia)/(SBP-DBP) and arterial distensibility = (DIAsys-213 
DIAdia)/[(SBP-DBP)·DIAdia], where SBP; systolic blood pressure, DBP; diastolic 214 
blood pressure, DIAmax; maximum diameter and DIAmin; minimum diameter.  215 
 216 
Study protocol 217 
Study participants visited the laboratory on a single occasion. Prior to 218 
instrumentation all study participants were carefully familiarized with the study 219 
design and measurements. Thereafter the carotid, internal carotid and vertebral 220 
arteries were scanned in each participant in order to exclude individuals with any 221 
stenosis. After instrumentation and a resting period of at least 5 min, a 3-min baseline 222 
was recorded prior to the start of the CPT. The CPT consisted of a 3-min immersion 223 
of the left foot into ice cold water (0.8±0.3°C) followed by a 3-min recovery. The foot 224 
was chosen, rather than the hand, in order to keep the upper body still and facilitate 225 
the acquisition of high quality ultrasound images. Throughout the CPT, isocapnia was 226 
maintained using an end-tidal forcing system (Air-force, GE Foster, Kelowna, BC, 227 
Canada) described in detail elsewhere (49). Briefly, PetCO2, PetO2, inspiratory and 228 
expiratory tidal volume were sampled on a breath-by-breath basis and with the help of 229 
a feedback control, and using independent gas solenoid valves for O2, CO2 and N2, 230 
desired end-tidal gases were maintained at baseline values. In order to assess whether 231 
there are any age-related alterations in thermal perception which may subsequently 232 
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contribute to any differences in CPT responses, each study participant was asked to 233 
provide a rating of the perceived pain, experienced at the onset and the end of the CPT 234 
using a Borg scale ranging from 0 (no pain) to 10 (worst pain). 235 
 236 
Data and statistical analysis 237 
Baseline (BL) values for the cardiovascular, respiratory and cerebrovascular 238 
variables measured were taken as an average over the last minute of the resting phase 239 
prior to the CPT. Thereafter, the last 20s of each minute was averaged during the CPT 240 
(CPT1, CPT2, CPT3) and throughout recovery (RE1, RE2, RE3). A repeated two-way 241 
ANOVA, was used to test for differences in the cardiovascular, respiratory and 242 
cerebrovascular responses with respects to experimental phase (BL, CPT1, CPT2, 243 
CPT3, RE1, RE2, RE3) and age (young, older). Data were expressed in absolute 244 
terms and as a percentage change from baseline, thus permitting us to compare the 245 
extra- and intra-cranial responses to the CPT and to ascertain the influence of age on 246 
these cerebrovascular responses. A repeated two-way ANOVA was used to determine 247 
whether perceived pain responses to the CPT were different with respects to 248 
experimental phase (CPT1, CPT2) and age (young, older). Finally, the existence of 249 
differences in arterial stiffness between experimental phases (BL, CPT) and age 250 
(young, older) was evaluated using a repeated two-way ANOVA. Tukey post hoc 251 
tests were used to examine significant main effects and interactions. Data are given as 252 
mean ± S.D unless otherwise indicated. Statistical significance was set at P < 0.05. 253 
Statistical analyses were performed using SAS Enterprise Guide (4.3, SAS Institute, 254 
Cary, NC).  255 
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RESULTS 256 
Cardiovascular and respiratory variables during baseline, CPT and recovery in 257 
young and older participants are presented in Table 1. During the CPT, MAP 258 
increased from baseline in both groups (P<0.01), but absolute values were higher in 259 
the older group throughout (P=0.03). In both groups, HR was increased similarly at 260 
CPT1 (P<0.01 vs. baseline) and declined thereafter. The PetCO2 was successfully 261 
kept at baseline values during the CPT by the end-tidal forcing system. Rating of 262 
perceived pain was not different between young and older groups at the onset (Young: 263 
5.8±1.4, Older: 4.6±2.6) and the end of the CPT (Young 4.4±2.1, Older: 5.4±2.6).  264 
During the CPT, MCAvmean and PCAvmean increased in the younger 265 
participants (by 19±19 and 11±12% at CPT2, respectively), whereas no changes from 266 
baseline were observed in the older participants (Figure 1). The CCA diameter 267 
increased in the young during CPT (by 5±3% at CPT1), whereas no change from 268 
baseline in CCA diameter was observed in the older participants (P<0.01, Figure 2). 269 
No changes from baseline in CCA velocity were observed in either age group, while 270 
CCA flow tended (P=0.08) to be increased in the young group. Both ICA diameter 271 
and ICA velocity were unchanged from baseline during the CPT, while ICA flow was 272 
increased from baseline at CPT1 (P=0.03). During the CPT, the percentage increase in 273 
CCA flow and MCAvmean were significantly greater than ICA flow in the young group 274 
(CCA vs. ICA P=0.02, CCA vs. MCA P=0.70, ICA vs. MCA P<0.01; Figure 3). 275 
However, in the older group the percentage increase in ICA flow and MCAvmean were 276 
significantly greater than CCA flow (CCA vs. ICA P=0.02, CCA vs. MCA P=0.05, 277 
ICA vs. MCA P=0.83). In the young group CPT evoked a greater velocity response in 278 
the MCA compared to the PCA (17±14% vs 10±10%, P<0.01), whereas no difference 279 
was seen in the older group (4±7% vs 3±7%, P=0.72). 280 
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Figure 4 provides the CVC values for the MCA, PCA, CCA and ICA during 281 
baseline, CPT and recovery in young and older participants. A significant interaction 282 
between age and experimental phase was observed for MCA CVC. Although MCA 283 
CVC was numerically lower in the older group across all experimental phases, post 284 
hoc analyses showed only a trend towards an age difference at CPT2 (P=0.07) with no 285 
significant differences from baseline in either group. 286 
Table 2 presents arterial stiffness indices for the CCA and ICA. Arterial 287 
stiffness in the CCA was greater in the older group compared to the young 288 
individuals, whereas ICA stiffness was not different. No index of arterial stiffness was 289 
altered during the CPT.   290 
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DISCUSSION 291 
The first major novel finding of the present study is that in young individuals 292 
there is a differential response to the CPT within the extra-cranial blood vessels (CCA 293 
vs. ICA) and also discrepant responses between the extra- and intra-cranial 294 
circulations. The second major novel finding is that in older individuals there is a 295 
blunting of the extra- and intra-cranial responses to the CPT. The physiological and 296 
clinical significance of these findings are considered below. 297 
 298 
1) Extra- and intra-cranial blood flow regulation during the cold pressor test:  299 
In accordance with earlier work in young individuals (53) we observed a 300 
significant increase in CCA diameter during the CPT. However, in contrast, and in 301 
accordance with our hypothesis, we observed no change in ICA diameter during the 302 
CPT. Despite this lack of change in ICA diameter and only a transient increase in ICA 303 
flow during the first minute of CPT, we observed that the CPT evoked a marked and 304 
persistent increase in MCAvmean – a finding in contrast to Bramanti et al. (3), but in 305 
agreement with several previous studies (46, 47, 56, 73). This may imply a differential 306 
regulation of the extra- and intra-cranial arteries that could serve an important 307 
protective role. There is evidence that the extra-cranial arteries (at the level of the ICA 308 
and vertebral arteries) are integral to the regulation of cerebral blood flow through 309 
modifying vascular resistance (14, 22, 29, 39, 40). Furthermore a MRI study reported 310 
decreased cerebral blood volume in response to sympathoexcitatory reflexes (69). In 311 
response to a sympathetically mediated hypertensive insult, the buffering function of 312 
the larger cerebral and large pial arterioles, but not the cerebral microcirculation, 313 
serves as a first line of defense in regulating cerebral perfusion pressure. Our data 314 
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indicate that the responses of the CCA are different from the ICA and MCA during 315 
the CPT, at least in younger individuals.  316 
Elevations in sympathetic vasoconstrictor activity and MAP produced by the 317 
CPT have at least three effects on cerebral blood flow. First, is the obvious hydraulic 318 
effect of MAP that increases flow even if vascular resistance is unchanged. Second, 319 
and the one commonly either neglected or misunderstood, is the autoregulatory effect 320 
of an increase in perfusion pressure to increase vascular resistance and minimise the 321 
increase in flow. A likely third effect is the influence of SNA on extra- and intra-322 
cranial blood flow regulation. Thus, appreciation of the effects of the CPT on factors 323 
such as the hydraulic effect and potential shear patterns of elevations in MAP, as well 324 
as the concomitant changes in SNA and autoregulation, likely explain the apparent 325 
differential mechanisms of regulation apparent between the CCA®ICA®MCA.  326 
Although the sympathetic regulation of the cerebral blood vessels in humans 327 
remains a controversial issue (1, 58), we did observe a decrease in MCA CVC (a 328 
finding consistent with other studies (21, 52)) and demonstrate for the first time that 329 
the CPT reduces CCA, ICA and PCA CVC. These latter changes in CVC are possibly 330 
indicative of sympathetically-mediated cerebral vasoconstriction or autoregulatory 331 
mediated. Bramanti et al. (3) demonstrated a reduction in MCAvmean during the CPT 332 
(by ~23%) the magnitude of which was approximately halved following intrathecal 333 
administration of the α2-adrenergic receptor agonist clonidine. These findings support 334 
the role of a central noradrenergic mechanism in the cerebrovascular responses to the 335 
CPT. However, although not measured in this study, differences in PaCO2 may 336 
explain these conflicting findings. In the present study, a dynamic end-tidal forcing 337 
system was used in an attempt to maintain PetCO2 near baseline, thus permitting the 338 
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effect of the generalized sympathetic activation associated with the CPT to be 339 
observed.  340 
Along with MCAvmean we determined the PCAvmean responses to CPT. There 341 
are known anatomical and physiological differences between anterior and posterior 342 
circulations. For example, the PCA may have less sympathetic innervation than the 343 
anterior cerebral portion (12, 20) and CO2 reactivity is reduced (51). We observed that 344 
the temporal pattern of response PCAvmean and MCAvmean was similar, however 345 
interestingly the magnitude of response was greater in the MCA compared to the PCA 346 
in the young (17±14% vs. 10±10%).  347 
 348 
2) Blunting of the extra- and intra-cranial responses during the CPT in older 349 
individuals: 350 
In contrast to the younger group, the changes in both the extra and intra-351 
cranial resistance and flow were generally blunted in the older group during the CPT. 352 
This is significant because dysfunctional CCA and coronary artery responses to the 353 
CPT have been associated with atherosclerotic disease (45, 53, 72). Since the MAP 354 
‘stimulus’ or hydraulic effect was comparable, it seems reasonable that the differential 355 
extra and intra-cranial responses in young and older individuals reflect some 356 
fundamental differences in potential shear patterns induced via the elevations in MAP, 357 
as well as the influences of SNA, humoral factors, endothelial vasodilator function, 358 
autoregulation and parasympathetic control. Rubenfire et al. (53), speculated that a b-359 
adrenergic mechanism accounted for the increase of CCA diameter during the CPT in 360 
healthy individuals, whereas the reduction in CCA diameter in coronary artery disease 361 
patients was due to greater sensitivity of the a-adrenergic receptors. This shift from a 362 
b-adrenergic vasodilatory response to an a-adrenergic vasoconstrictor one may be 363 
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related to underlying endothelial damage and dysfunction (71). Endothelial 364 
dysfunction is well established to occur within the peripheral vasculature of healthy 365 
elderly individuals and its extension to the cerebral vasculature might explain the 366 
present findings. Age-related alterations in arterial stiffness may also have contributed 367 
to the cerebrovascular responses reported. CCA stiffness was elevated in the older 368 
individuals at baseline, but in accordance with previous literature none of the 369 
calculated arterial stiffness indices was modified by the CPT (28, 33). Unfortunately, 370 
on the basis of our data set we cannot delineate the mechanism(s) for the blunting of 371 
the extra- and intra-cranial responses during the CPT in older individuals, but our 372 
findings provide direction for future studies.  373 
 374 
3) Methodological considerations:  375 
There are a number of methodological considerations that should be 376 
considered in the context of our study and related interpretation of the findings.   377 
a) Discrepancies of flow and velocity during the CPT: The assessment of 378 
cerebrovascular responses during a myriad of physiological interventions has been 379 
dominated by the use of transcranial Doppler over the last 30 years. However, this 380 
approach operates on the assumption (also its primary limitation) that the insonated 381 
vessel (PCA, MCA) remains at a constant diameter. Older studies have partially 382 
corroborated that under various stimuli (e.g., orthostasis, CO2 changes), MCAvmean 383 
accurately reflected the magnitude of changes in MCA blood flow as diameter 384 
remained unchanged (55), however, recent high resonance imaging studies have 385 
challenged this assumption of constant vessel diameter during marked changes in 386 
PaCO2 or PaO2 (8, 9, 64) or exercise-induced sympathetic activation (63). 387 
Furthermore, as recently reviewed (24), it is not known if the MCA diameter changes 388 
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during elevations in blood pressure. At least during hypertension (35) and 389 
hypotension (32), discrepancies between ICA flow and MCAvmean have been reported. 390 
Similarly, in the present study we observed that the percentage increase in ICA flow 391 
was less marked than MCAvmean during the CPT. The effects of CO2 and blood 392 
pressure on PCA diameter are unknown.  393 
b) Flow vs. conductance:  To account for MAP in the analysis of extra vs. 394 
intra-cranial cerebrovascular responses, CVC is commonly used. However, as 395 
outlined above, increases in MAP produced by the CPT may affect cerebral blood 396 
flow by several independent and interacting mechanisms (e.g., hydraulic effect, 397 
autoregulation, shear stress). As such, CVC is not likely to accurately account for the 398 
CPT-induced elevations in MAP during the CPT, and consideration of these 399 
mechanisms will be needed to fully understand the apparent differential regulation of 400 
the CCA®ICA®MCA.  401 
c) CPT recovery: We included recovery data in our analyses to verify that the 402 
cardiovascular, respiratory and cerebrovascular variables of interest returned to 403 
baseline following the CPT. In all instances the measured parameters did successfully 404 
recover. Interestingly, an elevated systolic blood pressure recovery from the CPT is an 405 
important predictor of a future elevation in systolic blood pressure (57). Whether there 406 
is any prognostic significance to the cerebrovascular response to or following the CPT 407 
remains to be investigated. 408 
 d) Study limitations: Roatta et al. (52), reported that the MCAvmean increases 409 
during hand CPT were slightly but significantly greater on the contralateral side 410 
(+4.4%) compared to the ipsilateral side (+2.4%). However, as the aim of our study 411 
was to simultaneous assess CCA, ICA, MCA and PCA responses to the CPT 412 
measurements were necessitated on both the contralateral and ipsilateral sides, thus 413 
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unfortunately it was not practical to account for any potential lateralization of the 414 
cerebral hemodynamic response to the CPT. In addition, hydration status was not 415 
assessed, which may be a limitation as this has recently been reported to modify the 416 
cerebrovascular response to the CPT (47). We cannot exclude the possibility that age-417 
related differences in thermoreceptor sensitivity contributed to the CPT responses we 418 
observed (15), although ratings of perceived pain were not different in the young and 419 
old groups during the CPT. One older individual was taking the α1A adrenoreceptor 420 
antagonist tamsulosin for an enlarged prostate. Although these receptors are present in 421 
the ureter, they are less well expressed in the peripheral vasculature (44, 50). This 422 
individual displayed cerebral perfusion similar responses to the rest of the older 423 
group, and their removal did not affect the results of the statistical analyses.  424 
It should be noted that our findings can only be directed to young and older 425 
healthy volunteers and that the regulation of cerebral blood flow may further differ in 426 
patients with cerebrovascular disease. Nevertheless, to be able to interpret the 427 
pathophysiological significance of these observations, a clear understanding of the 428 
normal responses of the cerebral circulation must first be obtained before extension 429 
can be made to pathological groups. Given that risk factors for coronary artery disease 430 
are associated with the extra-cranial blood vessel responses (53), future studies should 431 
explore the cerebrovascular responses in individuals at risk or in those that have 432 
experienced cerebrovascular events.  433 
 434 
4) Clinical implications:  435 
The CPT has been widely employed for cardiovascular risk stratification (6, 436 
38, 61). Likewise, an attenuated cerebrovascular reactivity is indicative of an 437 
increased risk for all cause and cardiovascular (inclusive of stroke) mortality (48). The 438 
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magnitude of the vasomotor response in the extracranial (ICA, vertebral artery) and 439 
intracranial arteries (MCA, PCA) to a CPT perturbation may be indicative of 440 
cerebrovascular health (i.e., endothelial function), much like peripheral flow mediated 441 
dilation is indicative of cardiovascular risk (18, 25). Thus future studies are needed to 442 
further explore vasomotor responses to CPT in individuals at risk of or who have 443 
experienced cerebrovascular events. Consequently, the CPT may serve as a simple 444 
diagnostic tool to predict cerebrovascular events and reduce related disabilities and 445 
mortality.  446 
 447 
In conclusion, during the CPT, for the first time we reveal; 1) differential 448 
mechanism(s) of regulation between the ICA compared to the CCA in young 449 
individuals; 2) a blunting of the extra- and intra-cranial responses in older individuals; 450 
and 3) irrespective of age, there were discrepancies in the magnitude of change in 451 
CCA flow, ICA flow and MCAvmean during the CPT.   452 
 21 
ACKNOWLEDGEMENTS 453 




This research was supported by a National Sciences and Engineering Research 458 
Council Discovery Grant (20150821-01; P.N.A.), Canadian Research Chair in 459 
Cerebrovascular Physiology (950-230970; P.N.A.), the Swiss National Science 460 
Foundation (P2ZHP3_158576; D.F.), National Institute for Health Research Efficacy 461 
and Mechanism Evaluation (12/10/19; J.P.F) and British Heart Foundation 462 
(PG/15/45/31579; J.P.F.). 463 
 464 
DISCLOSURES 465 
No conflicts of interest, financial or otherwise, are declared by the author(s). 466 




1. Ainslie PN, and Brassard P. Why is the neural control of cerebral 470 
autoregulation so controversial? F1000Prime Rep 6: 14, 2014. 471 
2. Auer LM, Edvinsson L, and Johansson BB. Effect of sympathetic nerve 472 
stimulation and adrenoceptor blockade on pial arterial and venous calibre and on 473 
intracranial pressure in the cat. Acta Physiol Scand 119: 213-217, 1983. 474 
3. Bramanti P, Mariani CA, D'Aleo G, and Malara A. The first in vivo 475 
experience of the effects of the continuous intrathecal infusion of clonidine on the 476 
locus coeruleus in the regulation of cerebral blood flow: a TCD study. Ital J 477 
Neurol Sci 18: 139-144, 1997. 478 
4. Bühler FR, Kiowski W, van Brummelen P, Amann FW, Bertel O, 479 
Landmann R, Lutold BE, and Bolli P. Plasma catecholamines and cardiac, 480 
renal and peripheral vascular adrenoceptor-mediated responses in different age 481 
groups of normal and hypertensive subjects. Clin Exp Hypertens 2: 409-426, 482 
1980. 483 
5. Burgmans S, Gronenschild EH, Fandakova Y, Shing YL, van Boxtel MP, 484 
Vuurman EF, Uylings HB, Jolles J, and Raz N. Age differences in speed of 485 
processing are partially mediated by differences in axonal integrity. Neuroimage 486 
55: 1287-1297, 2011. 487 
6. Carroll D, Davey Smith G, Willemsen G, Sheffield D, Sweetnam PM, 488 
Gallacher JE, and Elwood PC. Blood pressure reactions to the cold pressor test 489 
and the prediction of ischaemic heart disease: data from the Caerphilly Study. J 490 
Epidemiol Community Health 52: 528-529, 1998. 491 
7. Corretti MC, Plotnick GD, and Vogel RA. Correlation of cold pressor and 492 
flow-mediated brachial artery diameter responses with the presence of coronary 493 
artery disease. Am J Cardiol 75: 783-787, 1995. 494 
8. Coverdale NS, Gati JS, Opalevych O, Perrotta A, and Shoemaker JK. 495 
Cerebral blood flow velocity underestimates cerebral blood flow during modest 496 
hypercapnia and hypocapnia. J Appl Physiol (1985) 117: 1090-1096, 2014. 497 
9. Coverdale NS, Lalande S, Perrotta A, and Shoemaker JK. Heterogeneous 498 
patterns of vasoreactivity in the middle cerebral and internal carotid arteries. Am J 499 
Physiol Heart Circ Physiol 308: H1030-1038, 2015. 500 
10. Di Piero V, Ferracuti S, Sabatini U, Pantano P, Cruccu G, and Lenzi GL. A 501 
cerebral blood flow study on tonic pain activation in man. Pain 56: 167-173, 502 
1994. 503 
11. Dinenno FA, Dietz NM, and Joyner MJ. Aging and forearm postjunctional 504 
alpha-adrenergic vasoconstriction in healthy men. Circulation 106: 1349-1354, 505 
2002. 506 
 23 
12. Edvinsson L, Owman C, and Siesjo B. Physiological role of cerebrovascular 507 
sympathetic nerves in the autoregulation of cerebral blood flow. Brain Res 117: 508 
519-523, 1976. 509 
13. Ewing DJ, and Clarke BF. Diagnosis and management of diabetic autonomic 510 
neuropathy. Br Med J (Clin Res Ed) 285: 916-918, 1982. 511 
14. Faraci FM, Heistad DD, and Mayhan WG. Role of large arteries in regulation 512 
of blood flow to brain stem in cats. J Physiol 387: 115-123, 1987. 513 
15. Farage MA, Miller KW, Elsner P, and Maibach HI. Characteristics of the 514 
Aging Skin. Adv Wound Care (New Rochelle) 2: 5-10, 2013. 515 
16. Florian JP, Simmons EE, Chon KH, Faes L, and Shykoff BE. Cardiovascular 516 
and autonomic responses to physiological stressors before and after six hours of 517 
water immersion. J Appl Physiol (1985) 115: 1275-1289, 2013. 518 
17. Freeman R, and Chapleau MW. Testing the autonomic nervous system. Handb 519 
Clin Neurol 115: 115-136, 2013. 520 
18. Green DJ, Jones H, Thijssen D, Cable NT, and Atkinson G. Flow-mediated 521 
dilation and cardiovascular event prediction: does nitric oxide matter? 522 
Hypertension 57: 363-369, 2011. 523 
19. Halter JB, Stratton JR, and Pfeifer MA. Plasma catecholamines and 524 
hemodynamic responses to stress states in man. Acta Physiol Scand Suppl 527: 525 
31-38, 1984. 526 
20. Hamel E, Edvinsson L, and MacKenzie ET. Heterogeneous vasomotor 527 
responses of anatomically distinct feline cerebral arteries. Br J Pharmacol 94: 528 
423-436, 1988. 529 
21. Hartwich D, Fowler KL, Wynn LJ, and Fisher JP. Differential responses to 530 
sympathetic stimulation in the cerebral and brachial circulations during rhythmic 531 
handgrip exercise in humans. Exp Physiol 95: 1089-1097, 2010. 532 
22. Heistad DD, Marcus ML, and Abboud FM. Role of large arteries in regulation 533 
of cerebral blood flow in dogs. J Clin Invest 62: 761-768, 1978. 534 
23. Hines EA, and Brown G. A standard test measuring the variability of blood 535 
pressure. Its significance as an index of the prehypertensive state. Annals of 536 
Internal Medicine 209-217, 1933. 537 
24. Hoiland RL, and Ainslie PN. CrossTalk proposal: The middle cerebral artery 538 
diameter does change during alterations in arterial blood gases and blood 539 
pressure. J Physiol 2016. 540 
25. Inaba Y, Chen JA, and Bergmann SR. Prediction of future cardiovascular 541 
outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int 542 
J Cardiovasc Imaging 26: 631-640, 2010. 543 
 24 
26. Jeng JS, Yip PK, Huang SJ, and Kao MC. Changes in hemodynamics of the 544 
carotid and middle cerebral arteries before and after endoscopic sympathectomy 545 
in patients with palmar hyperhidrosis: preliminary results. J Neurosurg 90: 463-546 
467, 1999. 547 
27. Kang CK, Oh ST, Chung RK, Lee H, Park CA, Kim YB, Yoo JH, Kim DY, 548 
and Cho ZH. Effect of stellate ganglion block on the cerebrovascular system: 549 
magnetic resonance angiography study. Anesthesiology 113: 936-944, 2010. 550 
28. Kawano H, Tanimoto M, Yamamoto K, Sanada K, Gando Y, Tabata I, 551 
Higuchi M, and Miyachi M. Resistance training in men is associated with 552 
increased arterial stiffness and blood pressure but does not adversely affect 553 
endothelial function as measured by arterial reactivity to the cold pressor test. Exp 554 
Physiol 93: 296-302, 2008. 555 
29. Kontos HA, Wei EP, Navari RM, Levasseur JE, Rosenblum WI, and 556 
Patterson JL, Jr. Responses of cerebral arteries and arterioles to acute 557 
hypotension and hypertension. Am J Physiol 234: H371-383, 1978. 558 
30. Lakatta EG, and Levy D. Arterial and cardiac aging: major shareholders in 559 
cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular 560 
disease. Circulation 107: 139-146, 2003. 561 
31. Lakatta EG, and Levy D. Arterial and cardiac aging: major shareholders in 562 
cardiovascular disease enterprises: Part II: the aging heart in health: links to heart 563 
disease. Circulation 107: 346-354, 2003. 564 
32. Lewis NC, Smith KJ, Bain AR, Wildfong KW, Numan T, and Ainslie PN. 565 
Impact of transient hypotension on regional cerebral blood flow in humans. Clin 566 
Sci (Lond) 129: 169-178, 2015. 567 
33. Lim J, Pearman ME, Park W, Alkatan M, Machin DR, and Tanaka H. 568 
Impact of blood pressure perturbations on arterial stiffness. Am J Physiol Regul 569 
Integr Comp Physiol 309: R1540-1545, 2015. 570 
34. Liu J, Cao TS, Duan YY, Yang YL, and Yuan LJ. Effects of cold pressor-571 
induced sympathetic stimulation on the mechanical properties of common carotid 572 
and femoral arteries in healthy males. Heart Vessels 26: 214-221, 2011. 573 
35. Liu J, Zhu YS, Hill C, Armstrong K, Tarumi T, Hodics T, Hynan LS, and 574 
Zhang R. Cerebral autoregulation of blood velocity and volumetric flow during 575 
steady-state changes in arterial pressure. Hypertension 62: 973-979, 2013. 576 
36. Liu Y, Yang X, Gong H, Jiang B, Wang H, Xu G, and Deng Y. Assessing the 577 
effects of norepinephrine on single cerebral microvessels using optical-resolution 578 
photoacoustic microscope. J Biomed Opt 18: 76007, 2013. 579 
37. Lowe RF, and Gilboe DD. Demonstration of alpha and beta adrenergic receptors 580 
in canine cerebral vasculature. Stroke 2: 193-200, 1971. 581 
 25 
38. Matthews KA, Katholi CR, McCreath H, Whooley MA, Williams DR, Zhu S, 582 
and Markovitz JH. Blood pressure reactivity to psychological stress predicts 583 
hypertension in the CARDIA study. Circulation 110: 74-78, 2004. 584 
39. McHedlishvili GI. Vascular Mechanisms Pertaining to the Intrinsic Regulation 585 
of the Cerebral Circulation. Circulation 30: 597-610, 1964. 586 
40. McHedlishvili GI, Mitagvaria NP, and Ormotsadze LG. Vascular mechanisms 587 
controlling a constant blood supply to the brain ("autoregulation"). Stroke 4: 742-588 
750, 1973. 589 
41. Micieli G, Tassorelli C, Bosone D, Cavallini A, Viotti E, and Nappi G. 590 
Intracerebral vascular changes induced by cold pressor test: a model of 591 
sympathetic activation. Neurol Res 16: 163-167, 1994. 592 
42. Mineta Y, Morimoto M, Harano K, and Totoki T. [Sympathetic 593 
postganglionic innervation of external carotid artery, internal carotid artery, 594 
common carotid artery and aorta in the dog--experimental study using HRP and 595 
WGA-HRP]. Masui 41: 547-553, 1992. 596 
43. Mitchell DA, Lambert G, Secher NH, Raven PB, van Lieshout J, and Esler 597 
MD. Jugular venous overflow of noradrenaline from the brain: a neurochemical 598 
indicator of cerebrovascular sympathetic nerve activity in humans. J Physiol 587: 599 
2589-2597, 2009. 600 
44. Murata S, Taniguchi T, Takahashi M, Okada K, Akiyama K, and 601 
Muramatsu I. Tissue selectivity of KMD-3213, an alpha(1)-adrenoreceptor 602 
antagonist, in human prostate and vasculature. J Urol 164: 578-583, 2000. 603 
45. Nabel EG, Ganz P, Gordon JB, Alexander RW, and Selwyn AP. Dilation of 604 
normal and constriction of atherosclerotic coronary arteries caused by the cold 605 
pressor test. Circulation 77: 43-52, 1988. 606 
46. Panerai RB, Dawson SL, Eames PJ, and Potter JF. Cerebral blood flow 607 
velocity response to induced and spontaneous sudden changes in arterial blood 608 
pressure. Am J Physiol Heart Circ Physiol 280: H2162-2174, 2001. 609 
47. Perry BG, Bear TL, Lucas SJ, and Mundel T. Mild dehydration modifies the 610 
cerebrovascular response to the cold pressor test. Exp Physiol 101: 135-142, 611 
2016. 612 
48. Portegies ML, de Bruijn RF, Hofman A, Koudstaal PJ, and Ikram MA. 613 
Cerebral vasomotor reactivity and risk of mortality: the Rotterdam Study. Stroke 614 
45: 42-47, 2014. 615 
49. Querido JS, Ainslie PN, Foster GE, Henderson WR, Halliwill JR, Ayas NT, 616 
and Sheel AW. Dynamic cerebral autoregulation during and following acute 617 
hypoxia: role of carbon dioxide. J Appl Physiol (1985) 114: 1183-1190, 2013. 618 
50. Rajpathy J, Aswathaman K, Sinha M, Subramani S, Gopalakrishnan G, and 619 
Kekre NS. An in vitro study on human ureteric smooth muscle with the alpha1-620 
adrenoceptor subtype blocker, tamsulosin. BJU Int 102: 1743-1745, 2008. 621 
 26 
51. Reinhard M, Waldkircher Z, Timmer J, Weiller C, and Hetzel A. Cerebellar 622 
autoregulation dynamics in humans. J Cereb Blood Flow Metab 28: 1605-1612, 623 
2008. 624 
52. Roatta S, Micieli G, Bosone D, Losano G, Bini R, Cavallini A, and Passatore 625 
M. Effect of generalised sympathetic activation by cold pressor test on cerebral 626 
haemodynamics in healthy humans. Journal of the Autonomic Nervous System 627 
71: 159-166, 1998. 628 
53. Rubenfire M, Rajagopalan S, and Mosca L. Carotid artery vasoreactivity in 629 
response to sympathetic stress correlates with coronary disease risk and is 630 
independent of wall thickness. J Am Coll Cardiol 36: 2192-2197, 2000. 631 
54. Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, and Fox NC. A 632 
longitudinal study of brain volume changes in normal aging using serial 633 
registered magnetic resonance imaging. Arch Neurol 60: 989-994, 2003. 634 
55. Serrador JM, Picot PA, Rutt BK, Shoemaker JK, and Bondar RL. MRI 635 
measures of middle cerebral artery diameter in conscious humans during 636 
simulated orthostasis. Stroke 31: 1672-1678, 2000. 637 
56. Sohn YH. Cerebral hemodynamic changes induced by sympathetic stimulation 638 
tests. Yonsei Med J 39: 322-327, 1998. 639 
57. Stewart JC, and France CR. Cardiovascular recovery from stress predicts 640 
longitudinal changes in blood pressure. Biol Psychol 58: 105-120, 2001. 641 
58. Strandgaard S, and Sigurdsson ST. Point:Counterpoint: Sympathetic activity 642 
does/does not influence cerebral blood flow. Counterpoint: Sympathetic nerve 643 
activity does not influence cerebral blood flow. J Appl Physiol 105: 1366-1367; 644 
discussion 1367-1368, 2008. 645 
59. Takahashi R, Sakai T, Furuyama Y, Kondo Y, Inoue CN, Onuma S, and 646 
Iinuma K. The vasocontractive action of norepinephrine and serotonin in deep 647 
arterioles of rat cerebral gray matter. Tohoku J Exp Med 190: 129-142, 2000. 648 
60. Thomas KN, Lewis NC, Hill BG, and Ainslie PN. Technical recommendations 649 
for the use of carotid duplex ultrasound for the assessment of extracranial blood 650 
flow. Am J Physiol Regul Integr Comp Physiol 309: R707-720, 2015. 651 
61. Treiber FA, Kamarck T, Schneiderman N, Sheffield D, Kapuku G, and 652 
Taylor T. Cardiovascular reactivity and development of preclinical and clinical 653 
disease states. Psychosom Med 65: 46-62, 2003. 654 
62. Umeyama T, Kugimiya T, Ogawa T, Kandori Y, Ishizuka A, and Hanaoka 655 
K. Changes in cerebral blood flow estimated after stellate ganglion block by 656 
single photon emission computed tomography. J Auton Nerv Syst 50: 339-346, 657 
1995. 658 
63. Verbree J, Bronzwaer A, van Buchem MA, Daemen M, van Lieshout JJ, and 659 
van Osch M. Middle cerebral artery diameter changes during rhythmic handgrip 660 
exercise in humans. J Cereb Blood Flow Metab 271678X16679419, 2016. 661 
 27 
64. Verbree J, Bronzwaer AS, Ghariq E, Versluis MJ, Daemen MJ, van Buchem 662 
MA, Dahan A, van Lieshout JJ, and van Osch MJ. Assessment of middle 663 
cerebral artery diameter during hypocapnia and hypercapnia in humans using 664 
ultra-high-field MRI. J Appl Physiol (1985) 117: 1084-1089, 2014. 665 
65. Victor RG, Leimbach WN, Jr., Seals DR, Wallin BG, and Mark AL. Effects 666 
of the cold pressor test on muscle sympathetic nerve activity in humans. 667 
Hypertension 9: 429-436, 1987. 668 
66. Wagerle LC, Heffernan TM, Sacks LM, and Delivoria-Papadopoulos M. 669 
Sympathetic effect on cerebral blood flow regulation in hypoxic newborn lambs. 670 
Am J Physiol 245: H487-494, 1983. 671 
67. Willie CK, Colino FL, Bailey DM, Tzeng YC, Binsted G, Jones LW, 672 
Haykowsky MJ, Bellapart J, Ogoh S, Smith KJ, Smirl JD, Day TA, Lucas 673 
SJ, Eller LK, and Ainslie PN. Utility of transcranial Doppler ultrasound for the 674 
integrative assessment of cerebrovascular function. J Neurosci Methods 196: 221-675 
237, 2011. 676 
68. Willie CK, Tzeng YC, Fisher JA, and Ainslie PN. Integrative regulation of 677 
human brain blood flow. J Physiol 592: 841-859, 2014. 678 
69. Wilson TD, Shoemaker JK, Kozak R, Lee TY, and Gelb AW. Reflex-679 
mediated reduction in human cerebral blood volume. J Cereb Blood Flow Metab 680 
25: 136-143, 2005. 681 
70. Woodman RJ, Playford DA, Watts GF, Cheetham C, Reed C, Taylor RR, 682 
Puddey IB, Beilin LJ, Burke V, Mori TA, and Green D. Improved analysis of 683 
brachial artery ultrasound using a novel edge-detection software system. J Appl 684 
Physiol (1985) 91: 929-937, 2001. 685 
71. Young MA, and Vatner SF. Enhanced adrenergic constriction of iliac artery 686 
with removal of endothelium in conscious dogs. Am J Physiol 250: H892-897, 687 
1986. 688 
72. Zeiher AM, Drexler H, Wollschlaeger H, Saurbier B, and Just H. Coronary 689 
vasomotion in response to sympathetic stimulation in humans: importance of the 690 
functional integrity of the endothelium. J Am Coll Cardiol 14: 1181-1190, 1989. 691 
73. Zvan B, Zaletel M, Pretnar J, Pogacnik T, and Kiauta T. Influence of the cold 692 
pressor test on the middle cerebral artery circulation. J Auton Nerv Syst 74: 175-693 
178, 1998. 694 
 695 
  696 
 28 
FIGURE CAPTIONS 697 
Figure 1 698 
Middle cerebral artery mean blood flow velocity (MCAvmean) and posterior cerebral 699 
artery mean blood flow velocity (PCAvmean) in young (n=10, black circles) and old 700 
(n=9, n=8 for PCAvmean, grey triangles) at baseline (BL), during a three-minute cold 701 
pressor test (CPT1, CPT2, CPT3) and followed by a three-minute recovery (RE1, 702 
RE2, RE3). Values are means±SEM. P values represent repeated two-way ANOVA 703 
results.  *P < 0.05 vs. BL; d P < 0.05 vs. CPT1; + P < 0.05 vs. CPT2; § P < 0.05 vs. 704 
CPT3. 705 
 706 
Figure 2 707 
Common carotid (CCA) diameter, internal carotid (ICA) diameter, CCA velocity, 708 
ICA velocity, CCA flow and ICA flow in young (n=10, black circles) and old (n=9, 709 
n=7 for ICA, grey triangles) at baseline (BL), during a three-minute cold pressor test 710 
(CPT1, CPT2, CPT3) and followed by a three-minute recovery (RE1, RE2, RE3). 711 
Values are means±SEM. P values represent repeated two-way ANOVA results.  *P < 712 
0.05 vs. BL; d P < 0.05 vs. CPT1; + P < 0.05 vs. CPT2; § P < 0.05 vs. CPT3. 713 
 714 
Figure 3 715 
Percentage change from baseline (BL) in common carotid (CCA) flow, internal 716 
carotid (ICA) flow, and middle cerebral artery mean blood flow velocity (MCAvmean) 717 
in young (n=10, black symbols) and old (n=9, n=7 for ICA, grey symbols) during a 718 
three-minute cold pressor test (CPT1, CPT2, CPT3) and followed by a three-minute 719 
recovery (RE1, RE2, RE3). Values are means±SEM. P values represent repeated two-720 
way ANOVA results.   721 
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 722 
Figure 4 723 
Middle cerebral artery cerebrovascular conductance (MCA CVC), posterior cerebral 724 
artery (PCA) CVC, common carotid (CCA) CVC and internal carotid (ICA) CVC, in 725 
young (n=10, black symbols) and old (n=9, n=7 for ICA, grey symbols) at baseline 726 
(BL), during a three-minute cold pressor test (CPT1, CPT2, CPT3) and followed by a 727 
three-minute recovery (RE1, RE2, RE3). Values are means±SEM. P values represent 728 
repeated ANOVA results.  *P < 0.05 vs. BL; d P < 0.05 vs. CPT1; + P < 0.05 vs. 729 
CPT2; § P < 0.05 vs. CPT3730 
TABLES 
Table 1. Cardiovascular and respiratory parameters at baseline (BL), at each minute of a three minute cold pressor test (CPT1, CPT2, CPT3) and at each minute 
during a three-minute recovery (RE1, RE2, RE3). 
   Experimental phase 
 
 P values 
   
BL CPT1 CPT2 CPT3 RE1 RE2 RE3 
 
Age Phase Age* Phase 
              
MAP 
(mmHg) 
Y (n=10)  93±7 109±9 108±10 104±9 96±7 93±7 94±9  0.026 <0.001 0.79 
O (n=9)  101±7 114±10 114±9 112±8 104±6 102±5 103±5  
HR (bpm) Y (n=10)  73±12 81±18 77±17 73±15 67±12 69±13 68±11  0.105 <0.001 0.268 
O (n=9)  64±9 68±9 67±6 65±6 62±8 61±9 61±9  
SV (ml) Y (n=10)  96±42 93±42 90±41 90±42 94±43 94±42 95±42  0.271 0.046 0.855 
O (n=9)  93±30 89±28 88±28 86±26 89±27 90±27 87±27  
CO  
(l·min-1) 
Y (n=10)  7.4±1.1 8.0±2.0 7.3±1.6 7.2±1.3 6.8±1.1 7.0±0.9 6.9±1.0  0.005 0.002 0.505 




Y (n=10)  12.8±1.9 14.4±3.7 15.3±3.1 14.9±2.8 14.3±2.6 13.5±2.2 13.8±2.3  0.003 <0.001 0.806 
O (n=9)  20.4±7.3 22.9±7.6 22.9±6.8 23.6±6.3 22.3±6.8 21.5±6.5 22.6±6.8  
VE  
(l·min-1) 
Y (n=10)  14.6±3.8 18.4±5.4 18.2±5.0 18.1±4.8 16.1±3.7 14.8±3.1 15.1±3.2  0.038 <0.001 0.273 
O (n=9)  12.1±3.6 14.5±4.5 13.7±3.4 13.2±3.9 11.7±3.6 11.4±3.6 11.7±3.3  
PetCO2 
(mmHg) 
Y (n=10)  41.5±2.8 41.2±2.4 41.3±2.9 41.4±2.9 41.3±2.7 41.4±2.7 41.0±2.4  0.201 0.212 0.047 
O (n=9)  40.1±2.5 39.65±3.0 39.3±3.0 39.1±2.8 39.9±2.7 39.7±2.5 40.2±2.7§  
              
Abbreviations: MAP, mean arterial pressure; HR, heart rate; SV, stroke volume; CO, cardiac output; VE, ventilation; PetCO2, end-tidal partial pressure of CO2; 
Y, young; O, old. Values are mean±SD. P values represent two-way repeated ANOVA results (Age: young and old; Phase: BL, CPT1, CPT2, CPT3, RE1, RE2, 
RE3). §P < 0.05 versus CPT3. 
 
                      Table 2. Arterial stiffness indices in young and old individuals at baseline (BL) and during the cold pressure test (CPT) 
                       Abbreviations: CCA, common carotid artery; ICA, internal carotid artery; MCA, middle cerebral artery; PCA, posterior cerebral artery; BL, baseline;   








 P - value 
     Age Phase Age*Phase 
CCA β stiffness BL  5.5±1.1  7.6±2.3  0.001 0.980 0.843 
CPT  5.6±1.1  7.5±1.9  
ICA β stiffness BL  8.5±4.2  6.7±2.6  0.676 0.635 0.419 
CPT  8.0±4.9  8.6±2.2  
CCA Elastic modulus (mmHg) BL  555.9±129.5  796.3±198.2  <0.001 0.131 0.910 
CPT  636.9±126.1  890.2±219.1  
ICA Elastic modulus (mmHg) BL  846.6±384.4  698.4±264.9  0.879 0.227 0.383 
CPT  896.5±496.2  1000.8±269.5  
CCA Arterial compliance (cm·mmHg-1) BL  0.012±0.003  0.010±0.003  0.023 0.191 0.998 
CPT  0.011±0.002  0.009±0.002  
ICA Arterial compliance (cm·mmHg-1) BL  0.008±0.003  0.011±0.006  0.499 0.856 0.256 
CPT  0.009±0.005  0.009±0.005  
CCA Arterial distensibility (mmHg-1) BL  0.002±0.000  0.001±0.001  0.002 0.234 0.947 
CPT  0.002±0.000  0.001±0.000  
ICA Arterial distensibility (mmHg-1) BL  0.002±0.001  0.002±0.001  0.467 0.562 0.343 
CPT  0.003±0.006  0.001±0.000  
          
